Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney Disease

Stopped Due to company decision to focus resources on the finalisation of three ongoing studies in the region

Conditions

• Diabetes
• Diabetes Mellitus, Type 1
• Diabetes Mellitus, Type 2
• Chronic Kidney Disease

Interventions

• DRUG: insulin aspart

Sponsor

Novo Nordisk A/S